S&P 500 7,431.46 +0.50% NASDAQ 25,888.84 +0.31% DOW 51,202.26 +0.70% R2K 2,943.99 +0.79% VIX 17.68 -9.05% US 10Y 4.49 +0.54% DXY 99.75 -0.11% GOLD 4,215.00 +3.05% CRUDE 84.88 -3.23% BITCOIN 63,774.73 +0.36%
Next Bullish Trade
COR Cencora, Inc. NYQ
$281.67 +0.19 (+0.07%)
Neutral · +0.94σ Grade C
+ Compare Set alert Open in Sniper

Price chart

Overlay: Click earnings ▲ markers for day-move details

Loading 1Y daily…

Financial overlay · last 12 quarters

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $78.4B $1.6B $1.4B $1.2B 2.1% 1.7%
2025-12-31 $85.9B $0.6B $1.0B $-2.4B 0.7% 1.2%
2025-09-30 $83.7B $-0.3B $0.9B $2.9B -0.4% 1.1%
2025-06-30 $80.7B $0.7B $1.0B $-0.1B 0.9% 1.2%
2025-03-31 $75.5B $0.7B $1.2B $3.2B 1.0% 1.6%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Earnings replay · last 20 reports

DateEPS actual EPS estSurprise
2026-05-06 4.75 4.73 +0.5%
2026-02-04 4.08 4.04 +1.0%
2025-11-05 3.84 3.79 +1.4%
2025-08-06 4.00 3.84 +4.2%
2025-05-07 4.42 4.10 +7.9%
2025-02-05 3.73 3.52 +6.0%
2024-11-06 3.34 3.23 +3.5%
2024-07-31 3.34 3.22 +3.8%
2024-05-01 3.80 3.69 +2.9%
2024-01-31 3.28 2.89 +13.5%
2023-11-02 2.86 2.81 +1.9%
2023-08-02 2.92 2.83 +3.4%
2023-05-02 3.50 3.30 +6.1%
2023-02-01 2.71 2.63 +2.9%
2022-11-03 2.60 2.57 +1.0%
2022-08-03 2.62 2.56 +2.4%
2022-05-04 3.22 2.92 +10.2%
2022-02-02 2.58 2.58 +0.2%
2021-11-04 2.39 2.36 +1.5%
2021-08-04 2.16 2.04 +5.9%

Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).

Peer comparison · Healthcare

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
COR ★ $55B 21.6 14.2 0.2 12.8 16.1 3.8% 3.8% 128.3% -0.58%
LLY $1,010B 40.3 25.5 14.0 28.9 32.4 82.8% 55.5% 169.9% 0.91%
UNH $371B 30.8 19.5 0.8 19.8 3.8 18.8% 2.0% 0.7% 4.77%
JNJ $580B 27.9 18.9 6.0 17.9 7.1 68.0% 9.9% -52.9% 2.16%
MRK $294B 33.5 12.4 4.5 11.4 6.4 76.7% 4.9% — 4.78%
ABBV $402B 111.1 14.0 6.4 15.6 -60.5 72.0% 12.4% -46.2% 5.17%
PFE $149B 20.0 9.3 2.4 7.9 1.7 74.8% 5.4% -10.1% 8.29%
TMO $174B 25.8 17.2 3.9 19.0 3.3 40.9% 6.2% 11.3% 3.17%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Top institutional holders

Top-10 concentration: 44.38%

HolderShares% out
Blackrock Inc. 19,943,637 10.25%
Vanguard Capital Management LLC 12,313,459 6.33%
Vanguard Portfolio Management LLC 9,590,414 4.93%
State Street Corporation 9,190,551 4.72%
Price (T.Rowe) Associates Inc 7,323,706 3.76%
FMR, LLC 6,686,269 3.44%
T. Rowe Price Investment Management, 6,294,296 3.24%
Geode Capital Management, LLC 5,566,044 2.86%
JPMORGAN CHASE & CO 4,885,478 2.51%
Wellington Management Group, LLP 4,548,612 2.34%

Insider activity · 90d

5 buys / 0 sells · ratio 5.0 · Finnhub

  • DURCAN DERMOT MARK BUY 27,767 @ $266.26
  • Tyler Lauren M BUY 3,809 @ $304.00
  • NALLY DENNIS M BUY 13,075 @ $304.00
  • Cooper Ellen BUY 796 @ $304.00
  • Krikorian Lazarus BUY 3,936

Analyst estimates

Finnhub
Low
$280.0
Mean
$350.58334
High
$412.0
Analysts
12
Recommendation distribution · period 2026-06-01
5
11
4
Revision trend (2026-03-01 → 2026-06-01): net 19 → 16 -3 (net = strong_buy+buy − sell−strong_sell)

SEC filings

FormFiled DescriptionAction
8-K 2026-05-29 FORM 8-K view ·
4 2026-05-28 FORM 4 view ·
10-Q 2026-05-06 10-Q view ·
8-K 2026-05-06 8-K view ·
4 2026-05-05 FORM 4 view ·
4 2026-05-05 FORM 4 view ·
4 2026-05-05 FORM 4 view ·
4 2026-04-02 FORM 4 view ·
8-K 2026-03-23 FORM 8-K view ·
8-K 2026-03-17 FORM 8-K view ·
4 2026-03-13 FORM 4 view ·
4 2026-03-13 FORM 4 view ·
4 2026-03-13 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
8-K 2026-03-06 8-K view ·
4 2026-02-24 FORM 4 view ·
4 2026-02-20 FORM 4 view ·
8-K 2026-02-18 FORM 8-K view ·
8-K 2026-02-13 FORM 8-K view ·
8-K 2026-02-11 FORM 8-K view ·
8-K 2026-02-10 8-K view ·
10-Q 2026-02-04 10-Q view ·
8-K 2026-02-04 8-K view ·
4 2026-01-22 FORM 4 view ·
DEF 14A 2026-01-22 DEF 14A view ·
8-K 2026-01-22 FORM 8-K view ·
8-K 2026-01-16 FORM 8-K view ·
4 2026-01-07 FORM 4 view ·
4 2026-01-07 FORM 4 view ·
4 2025-12-22 FORM 4 view ·
4 2025-12-22 FORM 4 view ·
4 2025-12-22 FORM 4 view ·
4 2025-12-19 FORM 4 view ·
4 2025-12-19 FORM 4 view ·
4 2025-12-19 FORM 4 view ·
4 2025-12-19 FORM 4 view ·
4 2025-12-17 FORM 4 view ·
4 2025-12-17 FORM 4 view ·
4 2025-12-17 FORM 4 view ·
8-K 2025-12-15 FORM 8-K view ·
10-K 2025-11-25 10-K view ·
4 2025-11-24 FORM 4 view ·
4 2025-11-24 FORM 4 view ·
4 2025-11-24 FORM 4 view ·
4 2025-11-24 FORM 4 view ·
4 2025-11-24 FORM 4 view ·
4 2025-11-24 FORM 4 view ·
4 2025-11-19 FORM 4 view ·
4 2025-11-14 FORM 4 view ·
4 2025-11-14 FORM 4 view ·
4 2025-11-14 FORM 4 view ·

About

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; an…